Baxter International Inc. (BTL.F)
| Previous Close | 37.03 |
| Open | 34.30 |
| Bid | 33.92 x 13000 |
| Ask | 34.25 x 12700 |
| Day's Range | 33.99 - 34.30 |
| 52 Week Range | 29.45 - 44.20 |
| Volume | |
| Avg. Volume | 26 |
| Market Cap | 17.52B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.07 (2.90%) |
| Ex-Dividend Date | Feb 29, 2024 |
| 1y Target Est | N/A |
- Business Wire
Baxter Reports First-Quarter 2024 Results
DEERFIELD, Ill., May 02, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
- Business Wire
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
- Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.
